Introduction:
Reanalysis of the Women's Health Initiative has renewed debate on menopause hormone therapy (MHT) and cardiovascular risk. Whether MHT's cardiometabolic effects differ by formulation, route, or timing of initiation in women with or at risk for cardiovascular disease (CVD) remains unclear. This meta-ana...
Clarke Setrice Patricia, Daniel Mwesigwa Kiyimba, H. Ramteke et al.· Circulation· 0 citations
Introduction:
Resistant hypertension often persists despite multidrug therapy, driven by unopposed aldosterone activity. In May 2026, the FDA approved baxdrostat, a first-in-class aldosterone synthase inhibitor. Other agents include mineralocorticoid receptor antagonists (MRAs) such as spironolactone and eplerenone....
R. Khan, H. Ramteke, Sai Sravanth Reddy Tamma et al.· Circulation· 0 citations
A quantum-empowered degradation-aware V2G coordination framework for smart-city MMGs considering communication security and user travel demands that completely immunizes the system against FDIAs, effectively suppresses frequency fluctuations, and significantly reduces battery degradation costs while preserving user mob...
Hong-Bo Qiu, Chen-Xuan Zhang, Pei-Xiao Fan et al.· Applied Informatics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.